# CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome

> **NCT04404426** · NA · COMPLETED · sponsor: **Rennes University Hospital** · enrollment: 33 (actual)

## Conditions studied

- ARDS Secondary to COVID-19 Pneumonia

## Interventions

- **DIETARY_SUPPLEMENT:** L-citrulline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04404426
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-04
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-05-28
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404426, "CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04404426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*